Prostatype Genomics AB
Share Statistics
As of December 31, 2023, Prostatype Genomics AB TEMP has 315,692.80 shares outstanding.
| Shares Outstanding | 315,692.80 |
Financial Position
As of December 31, 2023, Prostatype Genomics AB TEMP maintains a current ratio of 1.06, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.06 |
| Quick Ratio | 0.11 |
| Debt / Equity | 47.28 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2023.
| Employee Count | 6.25 |
Stock Price Statistics
SEKAs of the close on August 6, 2026, Prostatype Genomics AB TEMP's stock has declined approximately 79.63% over the past 52 weeks.
| 52-Week Price Change | -79.63% |
| 50-Day Moving Average | 1.40 |
Balance Sheet
SEKAs of December 31, 2023, Prostatype Genomics AB TEMP holds 2.68M in cash and equivalents against 11.67M in total debt, resulting in a net debt position of 8.99M. Total book value stands at 24.67M, with working capital of 1.43M providing operational flexibility.
| Cash & Cash Equivalents | 2.68M |
| Total Debt | 11.67M |
| Net Debt | 8.99M |
| Equity (Book Value) | 24.67M |
| Book Value Per Share | 78.16 |
| Working Capital | 1.43M |
Cash Flow
SEKThese figures cover the twelve months ended December 31, 2023.
| Capital Expenditures | -69,910.00 |